8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2013 / Systematic review and meta-analysis
A systematic review and meta-analysis of eight studies with 61,386 participants and 3,988 events evaluated metabolic status and BMI categories. In studies with at least 10 years of follow-up, metabolically healthy obesity was associated with higher risk of mortality or cardiovascular events compared to metabolically healthy normal weight (RR 1.24; 95% CI 1.02 to 1.55). All metabolically unhealthy groups also demonstrated heightened risk.
Kramer CK, Zinman B, Retnakaran R Ann Intern Med, 2013. PMID 24297192
2013 / Systematic review and dose-response meta-analysis of cohort studies
A systematic review and random-effects dose-response meta-analysis of 22 prospective cohort study publications evaluated dietary fibre intake and cardiovascular outcomes. Total dietary fibre intake was inversely associated with risk of cardiovascular disease (risk ratio 0.91 per 7 g/day [95% CI 0.88 to 0.94]; I2=45%) and coronary heart disease (0.91 [0.87 to 0.94]; I2=33%). Insoluble fibre and fibre from cereal and vegetable sources were inversely associated with both cardiovascular disease and coronary heart disease risk, while fruit fibre intake was inversely associated with cardiovascular disease risk.
Shows an association, not proof of cause and effect.
Threapleton DE, Greenwood DC, Evans CE, et al. BMJ, 2013. PMID 24355537
2013 / Network meta-analysis of randomised controlled trials
A network meta-analysis evaluated 305 randomised controlled trials with 339,274 participants across 16 meta-analyses and three recent trials to compare exercise and drug interventions on mortality. No statistically detectable differences were observed between exercise and drug interventions in the secondary prevention of coronary heart disease and prediabetes. For stroke rehabilitation, exercise was more effective than anticoagulants (OR 0.09, 95% CrI 0.01 to 0.70) and antiplatelets (OR 0.10, 95% CrI 0.01 to 0.62), whereas diuretics were more effective than exercise in heart failure (OR 4.11, 95% CrI 1.17 to 24.76).
Naci H, Ioannidis JP BMJ, 2013. PMID 24473061
2012 / Bayesian meta-analysis of randomized controlled trials
A Bayesian meta-analysis of 17 randomized controlled trials evaluated the effect of isoflavone-containing soy products on endothelial function measured by FMD. The overall mean absolute change in FMD for isoflavone-containing soy product interventions was 1.15% (95% Bayesian CI: -0.52, 2.75). When analyzed separately, isolated isoflavones showed a treatment effect of 1.98% (95% Bayesian CI: 0.07, 3.97), whereas isoflavone-containing soy protein showed 0.72% (95% Bayesian CI: -1.39, 2.90). Models were not improved by accounting for cuff measurement location, dietary modifications, or baseline FMD.
Beavers DP, Beavers KM, Miller M, et al. Nutr Metab Cardiovasc Dis, 2012. PMID 20709515
2012 / Meta-analysis of randomized controlled trials
A meta-analysis of 11 randomized controlled trials evaluated the effect of dietary soy isoflavones on blood pressure. Overall, soy isoflavones resulted in a mean decrease of 2.5 mm Hg (95% CI: -5.35 to 0.34, P = 0.08) for systolic blood pressure (SBP) and 1.5 mm Hg (95% CI: -3.09 to 0.17, P = 0.08) for diastolic blood pressure (DBP) compared to placebo. In subgroup analyses of hypertensive subjects (5 trials), soy isoflavones significantly reduced SBP by -5.94 mm Hg (95% CI: -10.55 to -1.34, P = 0.01) and DBP by -3.35 mm Hg (95% CI: -6.52 to -0.19, P = 0.04). No significant reduction was found in normotensive subjects (6 trials; SBP: 0.29 mm Hg, P = 0.83; DBP: -0.43 mm Hg, P = 0.50). Authors noted larger trials are needed to confirm the findings.
Liu XX, Li SH, Chen JZ, et al. Nutr Metab Cardiovasc Dis, 2012. PMID 21310599
2012 / Systematic review and meta-analysis of randomized controlled trials
This study reviewed randomized controlled trial (RCT) evidence to clarify adverse events related to calcium supplementation and examine self-reported myocardial infarction (MI). In seven RCTs, self-reported gastrointestinal (GI) adverse event rates were significantly more common with calcium (14.1%) than placebo (10.0%; RR 1.43, 95% CI 1.28-1.59, p < 0.001). Adjudicated functional GI hospitalizations in one study were 6.8% with calcium versus 3.6% with placebo (RR 1.92, 95% CI 1.21-3.05, p = 0.006). In two trials comparing self-reported and adjudicated MI, self-reported MI was 3.6% with calcium and 2.1% with placebo, but after adjudication rates were 2.4% vs. 1.6% (RR 1.45, 95% CI 0.88-2.45, p = 0.145).
Lewis JR, Zhu K, Prince RL J Bone Miner Res, 2012. PMID 22139587
2012 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 42 RCTs involving 1,297 participants assessed the cardiovascular effects of chocolate, cocoa, and flavan-3-ols. Intake improved HOMA-IR (-0.67; 95% CI: -0.98, -0.36) via reductions in serum insulin, and enhanced FMD after chronic (1.34%; 95% CI: 1.00%, 1.68%) and acute (3.19%; 95% CI: 2.04%, 4.33%) intake. Reductions were seen in diastolic blood pressure (-1.60 mm Hg; 95% CI: -2.77, -0.43 mm Hg) and mean arterial pressure (-1.64 mm Hg; 95% CI: -3.27, -0.01 mm Hg). Evidence quality was low to moderate according to GRADE due to unclear reporting of allocation concealment, dropouts, missing outcome data, and biomarker heterogeneity.
Hooper L, Kay C, Abdelhamid A, et al. Am J Clin Nutr, 2012. PMID 22301923
2012 / Meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 29 randomized controlled trials evaluated the effects of oral vitamin C supplementation (median dose: 500 mg/d; median duration: 8 wk) on blood pressure. Vitamin C supplementation led to pooled reductions of -3.84 mm Hg (95% CI: -5.29, -2.38 mm Hg; P < 0.01) in SBP and -1.48 mm Hg (95% CI: -2.86, -0.10 mm Hg; P = 0.04) in DBP. In hypertensive participants, reductions in SBP and DBP were -4.85 mm Hg (P < 0.01) and -1.67 mm Hg (P = 0.17), respectively. Effects were attenuated but remained significant after including 9 trials with imputed BP effects.
Juraschek SP, Guallar E, Appel LJ, et al. Am J Clin Nutr, 2012. PMID 22492364
2012 / Meta-analysis of randomized controlled trials
A meta-analysis examined 14 double-blind randomized trials enrolling 20,485 individuals with prior cardiovascular conditions. Supplementation with eicosapentaenoic acid and docosahexaenoic acid did not lower overall cardiovascular event risk (RR 0.99; 95% CI, 0.89 to 1.09), heart attacks, strokes, or total mortality. An initial modest reduction in fatal cardiovascular events (RR 0.91; 95% CI, 0.84 to 0.99) disappeared after excluding one trial that had major methodological limitations.
Kwak SM, Myung SK, Lee YJ, et al. Arch Intern Med, 2012. PMID 22493407
2012 / Systematic review and meta-analysis of prospective cohorts and RCTs
Researchers systematically evaluated 45 prospective cohort studies and 21 RCTs investigating whole-grain and fiber intake. In prospective cohorts, consuming 48-80 g/d (3-5 servings/d) compared with never/rare intake was associated with lower risk of type 2 diabetes (RR = 0.74, 95% CI: 0.69, 0.80), lower risk of CVD (RR = 0.79, 95% CI: 0.74, 0.85), and less weight gain over 8-13 years (1.27 vs 1.64 kg; P = 0.001). In RCTs, whole-grain interventions significantly reduced post-intervention fasting glucose (-0.93 mmol/L, 95% CI: -1.65, -0.21), total cholesterol (-0.83 mmol/L, 95% CI: -1.23, -0.42), and LDL cholesterol (-0.82 mmol/L, 95% CI: -1.31, -0.33).
Ye EQ, Chacko SA, Chou EL, et al. J Nutr, 2012. PMID 22649266
2012 / Meta-analysis of randomized controlled trials and cohort studies
A meta-analysis examined whether intake of fish, fish oil, or long-chain omega-3 fatty acids influenced new-onset or recurrent atrial fibrillation. Across 11 randomized controlled trials, omega-3 fatty acids did not significantly reduce atrial fibrillation risk (OR=0.79; 95% CI, 0.56-1.12; p=0.19). Similarly, in seven cohort studies, exposure was not significantly associated with atrial fibrillation incidence (OR=0.83; 95% CI, 0.59-1.16; p=0.27).
Khawaja O, Gaziano JM, Djoussé L J Am Coll Nutr, 2012. PMID 22661621
2012 / Meta-analysis of prospective cohorts
A meta-analysis analyzed data from seven prospective cohort studies covering 124,706 participants from multiple countries. Vegetarian diets were associated with a significantly lower risk of ischemic heart disease mortality (RR = 0.71; 95% CI, 0.56-0.87) and lower overall cancer incidence (RR = 0.82; 95% CI, 0.67-0.97). Differences were not statistically significant for all-cause mortality (RR = 0.91; 95% CI, 0.66-1.16), circulatory disease mortality (RR = 0.84; 95% CI, 0.54-1.14), or cerebrovascular mortality (RR = 0.88; 95% CI, 0.70-1.06).
Shows an association, not proof of cause and effect.
Huang T, Yang B, Zheng J, et al. Ann Nutr Metab, 2012. PMID 22677895
2012 / Meta-analysis of randomized controlled trials
A meta-analysis evaluated 8 randomized controlled trials with 406 subjects free of chronic disease to compare the effects of beef versus poultry and/or fish on fasting lipoprotein lipids. Relative to the baseline diet, changes in mg/dL for beef versus poultry/fish were -8.1 ± 2.8 vs. -6.2 ± 3.1 for total cholesterol (P = .630), -8.2 ± 4.2 vs. -8.9 ± 4.4 for LDL cholesterol (P = .905), -2.3 ± 1.0 vs. -1.9 ± 0.8 for HDL cholesterol (P = .762), and -8.1 ± 3.6 vs. -12.9 ± 4.0 for triacylglycerols (P = .367). The authors concluded that changes in fasting lipid profiles were not significantly different between beef and poultry/fish consumption.
NANO counterpoint →
Maki KC, Van Elswyk ME, Alexander DD, et al. J Clin Lipidol, 2012. PMID 22836072
2012 / Meta-analysis of prospective and cross-sectional studies
A systematic review and meta-analysis of 18 studies (16 prospective, 2 cross-sectional) evaluated sedentary time in 794,577 adults. Comparing the highest sedentary time to the lowest, sitting was associated with increased risks of diabetes (RR 2.12; 95% CrI 1.61, 2.78), cardiovascular events (RR 2.47; 95% CI 1.44, 4.24), cardiovascular mortality (HR 1.90; 95% CrI 1.36, 2.66), and all-cause mortality (HR 1.49; 95% CrI 1.14, 2.03). Predictive effects were significant only for diabetes.
Shows an association, not proof of cause and effect.
Wilmot EG, Edwardson CL, Achana FA, et al. Diabetologia, 2012. PMID 22890825
2012 / Prospective cohort study and meta-analysis
A prospective cohort of 37,103 Swedish men evaluated chocolate intake over 10.2 years, identifying 1,995 incident strokes. Comparing the highest quartile (median 62.9 g/week) to the lowest (median 0 g/week), the relative risk was 0.83 (95% CI 0.70 to 0.99). A meta-analysis of five studies with 4,260 stroke cases showed an overall relative risk of 0.81 (95% CI 0.73 to 0.90) for highest versus lowest consumption.
Shows an association, not proof of cause and effect.
Larsson SC, Virtamo J, Wolk A Neurology, 2012. PMID 22933736
2012 / Meta-analysis of randomized controlled trials
A meta-analysis examined 20 randomized trials including 68,680 participants. Omega-3 supplementation was not statistically significantly associated with all-cause mortality (RR 0.96, 95% CI 0.91 to 1.02), cardiac death (RR 0.91, 95% CI 0.85 to 0.98; significance threshold P = .0063), sudden death, myocardial infarction, or stroke. Neither relative nor absolute risk reductions met the threshold for significance across major cardiovascular outcomes.
Rizos EC, Ntzani EE, Bika E, et al. JAMA, 2012. PMID 22968891
2012 / Systematic review and meta-analysis of prospective cohorts
Meta-analytic findings from prospective cohorts revealed that processed meat intake was linked to higher risk of coronary heart disease (RR per 50 g: 1.42, 95% CI = 1.07-1.89), while unprocessed red meat showed little or no risk. Both processed meat (RR per 50 g: 1.51, 95% CI = 1.25-1.83) and unprocessed meat (RR per 100 g: 1.19, 95% CI = 1.04-1.37) were associated with incident diabetes.
Shows an association, not proof of cause and effect.
Micha R, Michas G, Mozaffarian D Curr Atheroscler Rep, 2012. PMID 23001745
2012 / Meta-analysis of human intervention studies
In a pooled analysis of 16 records with 1,385 participants, fish oil supplementation improved flow-mediated dilation (weighed mean difference: 1.49%, 95% CI 0.48% to 2.50%, p = 0.004). However, study quality was inversely linked to the effect size, and a sensitivity analysis of double-blind, placebo-controlled trials showed no significant change (0.54%, 95% CI -0.25% to 1.33%). The authors concluded that higher-quality clinical trials are needed.
NANO counterpoint →
Xin W, Wei W, Li X PLoS One, 2012. PMID 23029372
2012 / Systematic review and meta-analysis of prospective studies
A meta-analysis of 15 prospective studies with 438,073 participants examined dietary glycemic index and glycemic load in relation to cardiovascular outcomes. Higher dietary glycemic load was associated with increased coronary heart disease risk in women (RR=1.49; 95% CI, 1.27-1.73), but not men (RR=1.08; 95% CI, 0.91-1.27), and with stroke (RR=1.19; 95% CI, 1.00-1.43). A linear dose-response was observed, with a 50-unit increase in glycemic load linked to a higher risk of coronary heart disease (RR=1.05; 95% CI, 1.02-1.08).
Shows an association, not proof of cause and effect.
Fan J, Song Y, Wang Y, et al. PLoS One, 2012. PMID 23284926
2011 / Meta-analysis of randomized controlled trials
Investigators conducted a meta-analysis of 10 randomized clinical trials evaluating the effects of non-soy legume consumption on blood lipids, with trials lasting at least 3 weeks. Among 268 participants analyzed using a random-effects model, the pooled mean net change in total cholesterol for those on a legume diet compared to control was -11.8 mg/dL (95% CI, -16.1 to -7.5). The mean net change in low-density lipoprotein cholesterol was -8.0 mg/dL (95% CI, -11.4 to -4.6).
Bazzano LA, Thompson AM, Tees MT, et al. Nutr Metab Cardiovasc Dis, 2011. PMID 19939654
2011 / Systematic review and meta-analysis of clinical trials
A systematic review and meta-analysis of 8 clinical trials evaluated mortality outcomes in 14,052 participants undergoing bariatric surgery versus 29,970 controls. Compared with controls, surgery was associated with reduced global mortality (OR = 0.55, CI, 0.49-0.63), cardiovascular mortality (OR = 0.58, CI, 0.46-0.73), and all-cause mortality (OR = 0.70, CI, 0.59-0.84). The reduction of risk was smaller in large studies than in small studies, and gastric bypass showed a greater effect on cardiovascular mortality than gastric banding (OR = 0.48 vs 0.71).
Pontiroli AE, Morabito A Ann Surg, 2011. PMID 21245741
2011 / Meta-analysis of observational studies
A meta-analysis of 18 observational studies evaluated tea intake and coronary artery disease. Highest green tea consumption was associated with lower disease risk (summary RR 0.72; 95% CI 0.58 to 0.89), and each one cup daily increment was linked to a 10% lower risk (summary RR 0.90; 95% CI 0.82 to 0.99). Black tea consumption showed no significant association with coronary artery disease across studies.
Shows an association, not proof of cause and effect.
Wang ZM, Zhou B, Wang YS, et al. Am J Clin Nutr, 2011. PMID 21248184
2011 / Meta-analysis of interventional studies
A meta-analysis of 44 interventional studies examined the impact of alcohol intake on coronary disease biomarkers in adults without cardiovascular disease. Alcohol intake increased HDL cholesterol (pooled mean difference 0.094 mmol/L, 95% CI 0.064 to 0.123), apolipoprotein A1 (0.101 g/L, 95% CI 0.073 to 0.129), and adiponectin (0.56 mg/L, 95% CI 0.39 to 0.72). It also decreased fibrinogen levels (-0.20 g/L, 95% CI -0.29 to -0.11) without altering triglyceride levels.
Brien SE, Ronksley PE, Turner BJ, et al. BMJ, 2011. PMID 21343206
2011 / Meta-analysis of randomized, placebo-controlled trials
A meta-analysis evaluated dose-response relationships for plant stanols and plant sterols on LDL-CH reductions across 113 publications and 1 unpublished report (182 strata). Maximal LDL-CH reductions for plant stanols (16.4%) and plant stanol ester (17.1%) were significantly greater than those for plant sterols (8.3%) and plant sterol ester (8.4%). Intakes of plant stanols exceeding the recommended 2 g/day dose were associated with additional, dose-dependent reductions in LDL-CH.
Musa-Veloso K, Poon TH, Elliot JA, et al. Prostaglandins Leukot Essent Fatty Acids, 2011. PMID 21345662